Pay in 4 interest-free payments of $6.12 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Immunogenicity: No Antibody Formation A critical safety consideration for any peptide therapy is immunogenicity, the potential to trigger immune system responses that could lead to allergic reactions, reduced efficacy through antibody neutralization, or autoimmune complications
No son medicamentos, suplementos, alimentos ni productos de consumo humano
The peptide has an arginine in place of glutamic acid at position 3, and an extra 13-amino-acid extension on the front (the N-terminus ), making the full chain 83 amino acids instead of native IGF-1's 70
BPC-157 and Nasal Delivery Despite mounting research on nasal peptide administration, studies on nasal delivery of BPC-157 are lacking
These symptoms matter diagnostically because they demonstrate that the worry is not purely psychological
In stock Specifications Compound: BPC-157 Quantity: 10mg per vial Form: Lyophilised powder Purity: 98% (batch specific) Appearance: White to off-white powder Use: Laboratory research only Quality & Verification Each batch undergoes analytical testing to confirm identity and purity
US$ 23.15
US$ 28.79
US$ 22.54
US$ 21.19
US$ 29.14
